Back to results
US 6,635,669 B2Granted
Isomeric fused pyrrolocarbazoles and isoindolones
AssigneeCephalon, Inc.
InventorRobert L. Hudkins
Life of this patent
Estimating the term…
Abstract
The present invention is directed to novel fused pyrrolocarbazoles and isoindolones, including pharmaceutical compositions, diagnostic kits, assay standards or reagents containing the same, and methods of using the same as therapeutics. The invention is also directed to intermediates and processes for making these novel compounds.
Claims15
A compound of Formula I:
- or a stereoisomer or pharmaceutically acceptable salt form thereof, wherein:
- ring D is selected from phenyl and cyclohexene with double bond a-b;
- ring B and ring F, independently, and each together with the carbon atoms to which they are attached, are selected from a 6-membered carbocyclic ring;
- G—X—W is selected from:
- a) —(A1A2)C—N(R1)—C(B1B2)—;
- b) —CH(R1A)—C(═O)—N(R1)—;
- and
- c) —N(R1)—C(═O)—CH(R1A)—;
- R1 is selected from:
- a) H, substituted or unsubstituted alkyl of 1 to 6 carbons, substituted or unsubstituted aryl, substituted or unsubstituted arylalkyl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted heteroarylalkyl;
- b) —C(═O)R7, where R7 is selected from substituted or unsubstituted alkyl, substituted or unsubstituted aryl, substituted or unsubstituted carbocyclic group, and substituted or unsubstituted heterocyclyl groups;
- c) —OR8, where R8 is selected From H and alkyl having from 1 to 6 carbons;
- d) —C(═O)NHR8, —NR9R10, —(CH2)pNR9R10, —(CH2)pOR8, —O(CH2)pOR8 and —O(CH2)pNR9R10, where p is from 1 to 4;
- and where either
- 1) R9 and R10 are each independently selected from H, unsubstituted alkyl of 1 to 6 carbons, and substituted alkyl;
- or
- 2) R9 and R10 together form a linking group of the formula —(CH2)2—X1—(CH2)2—, wherein X1 is selected from —O—, —S—, and —CH2—;
- R1A is the same as R1;
- R2, R3, R4 and R5 are each independently selected from:
- a) H, aryl, carbocyclyl, heterocyclyl, —CN, CF3, —NO2, —OH, —OR7, Br, I, —O(CH2)pNR9R10, —OC(═O)R7, —OC(═O)NR9R10, —O(CH2)pOR8, F, Cl, —CH2OR8, —NR9R10, —NR8S(═O)2R7, —NR8C(═O)R7, or —NR8C(═S)R7;
- b) —CH2OR11, where R11 is the residue of an amino acid after the hydroxyl group of the carboxyl group is removed;
- c) —NR8C(═O)NR9R10, —NR8C(═S)NR9R10, —CO2R12, —C(═O)R12, —C(═O)NR9R10, —C(═S)NR9R10, —CH═NOR12, —CH═NR7, —(CH2)pNR9R10, —(CH2)pNHR11, or —CH═NNR12R12A;
- where
- R12 is selected from H, alkyl of 1 to 6 carbons, —OH, alkoxy of 1 to 6 carbons, —OC(═O)R7, —OC(═O)NR9R10, —OC(═S)NR9R10, —O(CH2)pNR9R10, —O(CH2)pOR8, substituted or unsubstituted arylalkyl having from 6 to 10 carbons, substituted or unsubstituted heterocyclylalkyl, and a substituted or unsubstituted carbocyclic group;
- R12A is the same R12;
- d) —S(O)yR12, —(CH2)pS(O)yR7, —CH2S(O)yR11 where y is 0, 1 or 2;
- e) alkyl of 1 to 8 carbons, alkenyl of 2 to 8 carbons, and alkynyl of 2 to 8 carbons, wherein:
- 1) each alkyl, alkenyl, or alkynyl group is unsubstituted;
- or
- 2) each alkyl, alkenyl or alkynyl group is substituted with 1 to 3 groups selected from aryl of 6 to 10 carbons, heterocyclyl, arylalkoxy, heterocycloalkoxy, hydroxylalkoxy, alkytoxy-alkoxy, hydroxyalkylthio, alkoxy-alkylthio, F, Cl, Br, I, —CN, —NO2, —OH, —OR7, —X2CH2)pC(═O)NR9R10, —X2(CH2)—C(═S)NR9R10, —X2(CH2)pOC(═O)NR9R10, —X2(CH2)pCO2R7, —X2(CH2)pS(O)yR7, —X2(CH2)pNR8C(═O)NR9R10, —OC(═O)R7, —OC(═O)NHR12, O-tetrahydropyranyl, —NR9R10, —NR8CO2R7, 13 NR8C(═O)NR9R10, —NR8C(═S)NR9R10, —NHC(═NH)NH2, —NR8C(═O)R7, —NR8C(═S)R7, —NR8S(═O)2R7, —S(O)yR7, —CO2R12, —C(═O)NR9R10, —C(═S)NR9R10, —C(═O)R12, —CH2OR8, —CH═NNR12R12a, —CH═NOR12, —CH═NR7, —CH═NNHCH(N═NH)NH2, —S(═O)2NR12R12A, —P(═O)(OR8)2, and —OR11, and a monosaccharide of 5 to 7 carbons where each hydroxyl group of the monosaccharide is independently either unsubstituted or is replaced by H, alkyl of 1 to 4 carbons, alkylcarbonyloxy of 2 to 5 carbons, or alkoxy of 1 to 4 carbons;
- X2is O, S, or NR8;
- Q is selected from —NR6;
- R6 is selected from —H, —SO2R7, —CO2R7, —CO(═O)R7, —C(═O)NR9R10, alkyl of 1-8 carbons, alkenyl of 2-8 carbons, and alkynyl of 2-8 carbons;
- and either
- 1) each alkyl, alkenyl, or alkynyl group is unsubstituted;
- or
- 2) each alkyl, alkenyl, or alkynyl group independently is substituted, as defined for R2, R3, R4, and R5 in e) above;
- Y is selected from:
- a) an unsubstituted alkylene of 2 carbons;
- b) an alkylene of 2 carbons substituted with R13, where R13 is selected from R2thioalkyl of 1-4 carbons, halogen, alkyl of 1-8 carbons, alkenyl of 2-8 carbons, and alkynyl of 2-8 carbons, where
- i) each alkyl of 1-8 carbons, alkenyl of 2-8 carbons, and alkynyl of 2-8 carbons is unsubstituted;
- or
- ii) each alkyl of 1-8 carbons, alkenyl of 2-8 carbons, and alkynyl of 2-8 carbons, independently, is substituted, as defined for R2, R3, R4, and R5 in e) above;
- and
- c) a functional group selected from —CH═CH—, —CH(OH)—CH(OH)—, —C═C(R13)2—, —C(═O)CH(R6)—, —CH(R6)C(═O)—, —C(═NOR12)CH(R6)—, —CHR8C(═NOR12)—, —CH2Z—, —ZCH2—, where Z is selected from —C(R12)—;
- A1 and A2 are selected from H, H;
- H, OR12;
- H, —SR12;
- H, —N(R12)2;
- and a group where A1 and A2 together form a moiety selected from ═O, ═S, and ═NR12;
- and,
- B1 and B2 are selected from H, H;
- H, —OR12;
- H, —SR12;
- H, —N(R12)2;
- and a group where B1 and B2 together form a moiety selected from ═O, ═S, and ═NR12;
- with the proviso that at least one of the pairs A1 and A2, or B1 and B2, form ═O.
54 more elements
Dependencies are inferred from the claim text.